Genetic polymorphisms in promoter and intronic regions of CYP1A2 gene in Roma and Hungarian population samples

Environ Toxicol Pharmacol. 2014 Nov;38(3):814-20. doi: 10.1016/j.etap.2014.09.012. Epub 2014 Sep 28.

Abstract

The purpose of this study was to determine the interethnic differences of four CYP1A2 drug metabolizing enzyme variants. A total of 404 Roma and 396 Hungarian healthy subjects were genotyped for -163C>A, -729C>T, -2467delT and -3860G>A variants of CYP1A2 by RT-PCR and PCR-RFLP technique. The -3860A and -729T allele were not detectable in Roma samples, while in Hungarian samples were present with 2.02% and 0.25% prevalence, respectively. There was a 1.5-fold difference in presence of homozygous -163AA genotype between Hungarian and Roma samples (49.5% vs. 31.9%, p<0.001). The -163A allele frequency was 68.6% in Hungarians and 56.9% in Romas (p=0.025). The -2467delT allele frequency was 6.81% in Roma group and 5.81% in Hungarians. The most frequent allelic constellation was -3860G/-2467T/-729C/-163A in both populations. In conclusion, Hungarians have markedly elevated chance for rapid metabolism of CYP1A2 substrates, intensified procarcinogen activation and increased risk for cancers.

Keywords: CYP1A2; Hungarian; Interethnic; Pharmacogenetics; Polymorphisms; Roma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cytochrome P-450 CYP1A2 / genetics*
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Healthy Volunteers
  • Homozygote
  • Humans
  • Introns
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Prevalence
  • Promoter Regions, Genetic
  • Risk Factors
  • Roma / ethnology
  • Roma / genetics*
  • Young Adult

Substances

  • CYP1A2 protein, human
  • Cytochrome P-450 CYP1A2